Revision history of "Robust and adaptive biological platforms for new vaccines — RAMTOVAX" (Q2727827)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

8 October 2024

  • curprev 22:2422:24, 8 October 2024DG Regio talk contribs 47,569 bytes +8 Set a claim value: summary (P836): O projecto propõe o desenvolvimento de uma nova forma de vacinas, nomeadamente a criação de uma plataforma nanopic universal baseada numa proteína recombinante do tipo 2 do vírus (HPIV2), que será um portador não-infeccioso da proteína em determinantes do antigene de outros vírus patogénicos. Estas soluções têm características tecnológicas superiores aos potenciais substitutos e aos produtos concorrentes de hoje, principalmente do ponto de vista da...

12 August 2024

22 March 2024

11 June 2023

1 June 2023

12 October 2022

11 July 2022

  • curprev 00:4600:46, 11 July 2022DG Regio talk contribs 46,561 bytes +27,078 Changed label, description and/or aliases in da, el, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et, hr, nl, fr, de, it, es, and other parts: Adding translations: da, el, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et,

23 May 2022

13 January 2022

11 January 2022

4 December 2021

29 November 2021

  • curprev 18:5518:55, 29 November 2021DG Regio talk contribs 15,130 bytes +1,342 Created claim: summary (P836): Das Projekt schlägt die Entwicklung einer neuen Form von Impfstoffen vor, d. h. die Schaffung universeller Nanoplattformen auf der Grundlage des rekombinanten Proteins des humanen Parainfluenza-Virus Typ 2 (HPIV2), das anpassungsfähige Protein nicht infektiöse Träger von Antigendeterminanten anderer pathogener Viren sein wird. Diese Lösungen haben überlegene technologische Eigenschaften gegenüber potenziellen Ersatzstoffen und heute konkurrieren...
  • curprev 18:5518:55, 29 November 2021DG Regio talk contribs 13,788 bytes +146 Changed label, description and/or aliases in de: translated_label

26 November 2021

  • curprev 11:4211:42, 26 November 2021DG Regio talk contribs 13,642 bytes +1,276 Created claim: summary (P836): Projektom se predlaže razvoj novog oblika cjepiva, odnosno kreiranje univerzalnih nanoplatformi temeljenih na rekombinantnom proteinu virusa humane parainfluence tipa 2 (HPIV2) koje će biti prilagodljivi proteinskiski neinfektivni nosači antigenskih determinanti drugih patogenih virusa. Ova rješenja posjeduju superiorne tehnološke karakteristike spram potencijalnih supstituta i danas konkurentskih proizvoda, prvenstveno s aspekta učinkovitosti.,...
  • curprev 09:4509:45, 26 November 2021DG Regio talk contribs 12,366 bytes +144 Changed label, description and/or aliases in fr: translated_label

21 June 2021

8 June 2021

3 June 2021

  • curprev 09:4409:44, 3 June 2021DG Regio talk contribs 11,791 bytes +129 Changed label, description and/or aliases in en: translated_label
  • curprev 09:4409:44, 3 June 2021DG Regio talk contribs 11,662 bytes +1,268 Created claim: summary (P836): The project proposes the development of a new form of vaccines, namely the creation of a universal nanopic platform based on a recombinant protein-Type 2 protein (HPIV2) virus, which will be a protein non-infectious carrier on antigene determinants of other pathogenic viruses. These solutions have superior technological characteristics against potential substitutes and today’s competing products, primarily from the efficiency point of view., tra...

2 June 2021